Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Bofa $3 target

Their low valuation is based on getting a maximum of only 2% of the prandial insulin market 3% of the oral combo market. Obviously if the market penetration is greater then the valuation will be higher.

Share
New Message
Please login to post a reply